✦ LIBER ✦

TGF-β1 and BRCA2 Expression are Associated with Clinical Factors in Breast Cancer

✍ Scribed by Junchuan Li; Hongyu Zhu; Tingxuan Chen; Guihua Dai; Lanying Zou

Book ID: 107567790
Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 286 KB
Volume: 60
Category: Article
ISSN: 1085-9195
DOI: 10.1007/s12013-010-9146-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast cancer risk associated with BRCA1

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

✍ Fackenthal, James D.; Olopade, Olufunmilayo I. 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 504 KB

TGF-β1 mRNA expression in clinical breas

TGF-β1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expression

✍ K.D. Amoils; W.R. Bezwoda 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 44 KB

Contralateral recurrence and prognostic

Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer

✍ M. M. A. Tilanus-Linthorst; C. Alves; C. Seynaeve; M. B. E. Menke-Pluymers; A. M 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Early use of clinical BRCA1/2 testing: A

Early use of clinical BRCA1/2 testing: Associations with race and breast cancer risk

✍ Katrina Armstrong; Barbara Weber; Jill Stopfer; Kathleen Calzone; Mary Putt; Jam 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

Clinical and Pathologic Differences Betw

Clinical and Pathologic Differences BetweenBRCA1-,BRCA2-, and Non-BRCA-Associated Breast Cancers in a Multiracial Developing Country

✍ Cheng-Har Yip; N. A. Taib; W. Y. Choo; S. Rampal; M. K. Thong; S. H. Teo 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 174 KB

Elevated expression of TGF-β1 in head an

Elevated expression of TGF-β1 in head and neck cancer–associated fibroblasts

✍ Eben Rosenthal; Allison McCrory; Melissa Talbert; Geoff Young; Joanne Murphy-Ull 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

## Abstract Head and neck cancers are characterized by a vigorous desmoplastic response, but the contribution of stromal‐derived growth factors to the tumor microenvironment is poorly understood. We evaluated the expression of stromal growth factor expression in head and neck squamous cell carcinom